Access to Information Requests Completed - May 2011

This content was archived on June 24, 2013.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of May 2011

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2008-00484	All briefs and submissions tabled within the consultation for the "Promotion of Tobacco Products and Accessories Regulations (Prohibited Terms)" launched on August 7, 2007 and ending on October 18, 2007.	Disclosed in part	98
A-2008-00989	All records on the issue of health claims and other claims related to energy drinks currently for sale in Canada. (Jan 1, 2008 to Feb 20, 2009).	Disclosed in part	650
A-2008-00999	From 1952 to 2004, all available documentation relating to: Health population viability, concentration of toxins in fish, shellfish & marine invertebrates & associated sediments for the coast of Quadra Island.	Disclosed in part	2,626
A-2009-00189	All email correspondence at Health Canada (headquarters only) about the issue of granting the food industry discretionary authority to fortify foods (including junk food), including any discussions of proposed regulations.  (Sep 1, 2008 to May 15, 2009).	Disclosed in part	134
A-2009-00540	A copy of the National Dose Registry. (2000 to Sep 22, 2009).	All disclosed	5,000
A-2009-00605	First Nations and Inuit Health Branch documents related to the public health pilot project and pandemic plan.	Disclosed in part	380
A-2009-00913	Medical devices that precipitated an adverse event deemed counterfeit: database from 2005 to November 6, 2009.	Disclosed in part	4
A-2009-01388	All documents related to Caffeinated Energy Drinks and the proposed Abbreviated Labelling Standard for Caffeinated Energy Drinks.	Disclosed in part	2,106
A-2009-01447	Information regarding the product Zinc gluconate, NPN 1900463 by Bio Pak Inc.	Disclosed in part	20
A-2010-00183	All records relating to the March, 2010 decision by Health Canada to lift the ban on synthetic caffeine in non-cola soft drinks. (June 1, 1994 to May 13, 2010).	Disclosed in part	40
A-2010-00194	Communications with the Minister of Health regarding warning labels on alcohol bottles and containers about the dangers of drinking during pregnancy and/or Fetal Alcohol Spectrum Disorder and/or Fetal Alcohol Syndrome. (Jan 1, 2001 to Jan 15, 2002).	Disclosed in part	13
A-2010-00195	Communications with the Minister of Health regarding warning labels on alcohol bottles and containers about the dangers of drinking during pregnancy and/or Fetal Alcohol Spectrum Disorder and/or Fetal Alcohol Syndrome. (Jan 16, 2002 to Dec 11, 2003).	Disclosed in part	325
A-2010-00196	Communications with the Minister of Health regarding warning labels on alcohol bottles and containers about the dangers of drinking during pregnancy and/or Fetal Alcohol Spectrum Disorder and/or Fetal Alcohol Syndrome. (Dec 12, 2003 to Jul 19, 2004).	Disclosed in part	54
A-2010-00197	Communications with the Minister of Health regarding warning labels on alcohol bottles and containers about the dangers of drinking during pregnancy and/or Fetal Alcohol Spectrum Disorder and/or Fetal Alcohol Syndrome. (Jul 20, 2004 to Feb 5, 2006).	Disclosed in part	41
A-2010-00198	Communications with the Minister of Health regarding warning labels on alcohol bottles and containers about the dangers of drinking during pregnancy and/or Fetal Alcohol Spectrum Disorder and/or Fetal Alcohol Syndrome. (Feb 6, 2006 to Oct 29, 2008).	Disclosed in part	35
A-2010-00199	Communications with the Minister of Health regarding warning labels on alcohol bottles and containers about the dangers of drinking during pregnancy and/or Fetal Alcohol Spectrum Disorder and/or Fetal Alcohol Syndrome. (Oct 30, 2008 to May 17, 2010).	Disclosed in part	52
A-2010-00292	Current Standing Offers for Short term nurse relief services, Solicitation number H3551-081973/A.	Disclosed in part	188
A-2010-00376	AERs for the product Revlimid. Report numbers: 000331191, 000332565, 000333198, 000332569, 000340537, 000333875 and 000335123.	Disclosed in part	40
A-2010-00383	Information regarding the product Ginkgo Biloba 60mg Soft Gel Capsules, NPN 80003467 by Swiss Herbal Remedies Ltd /TheraPro.	Disclosed in part	39
A-2010-00516	Information regarding the product VIT.D3 DROPS 400IU, NPN 80001869 by Ddrops Company.	Disclosed in part	65
A-2010-00627	Medical devices authorized for sale in Canada pursuant to Licence 328 (namely infusion or volumetric pumps as well as parts, fittings and accessories) believed to be sold in association with the trade-mark Colleague by or on behalf of Baxter Healthcare Corporation. (2002 to Aug 30, 2010).	Disclosed in part	847
A-2010-00671	Copies of records involved in contributing to the announcement on September 1, 2010 of the decision of the Health Minister to agree to the recommendations of the CIHR on chronic cerebrospinal venous insufficiency (CCSVI).  (July and August 2010).	Disclosed in part	103
A-2010-00733	All records related to caffeine in non-cola carbonated beverages. (Feb 1, 2010 to Sep 1, 2010).	Disclosed in part	481
A-2010-00735	Information regarding the product Cyclessa, DINs 02257238 and 02252903.	Disclosed in part	180
A-2010-00763	Listing of all committee working groups that were created in which Health Canada chaired or co-chaired regarding the 2010 Winter Olympic Games. (Jul 2, 2007 to Sep 1, 2010).	Disclosed in part	90
A-2010-00801	Relating to the H1N1virus, all documents approved at the Deputy Minister and Assistant Deputy Minister level that were directed to their counterparts in: the Canadian federal government, Mexican and American federal governments, the United Nations relating to preparation for containing the epidemic including any emergency procedures. (Apr 1 2010 to Sep 30, 2010).	All disclosed	37
A-2010-00809	Information regarding the products Colgate Sensitive Pro-Relief and Colgate Sensitive Pro-Relief Whitening, NPN 80017891 by Colgate Palmolive Canada Inc.	Disclosed in part	597
A-2010-00844	Information regarding the product Apo-risedronate, DIN 02353687 by Apotex Inc.	Disclosed in part	94
A-2010-00855	All documents relating to Project Number 1385; the proposal and eventual decision to amend Part II of Schedule F to the Food and Drug Regulations to provide exemptions to allow non-prescription status for vitamin K1 and K2 in products intended for external use in humans.	Disclosed in part	338
A-2010-00866	Information regarding the product Onglyza  by Bristol-Myers Squibb Canada.	Disclosed in part	698
A-2010-00882	Copies of records concerning the decision of Health Canada to postpone or abandon plans to update cigarette-package warnings. (Nov 20, 2009 to Nov 19, 2010).	Disclosed in part	65
A-2010-00901	All records related to public-opinion research about the effectiveness of images of Barb Tarbox as health warning on the panel of cigarette packs. (Jan 1, 2005 to Dec 31, 2008).	All disclosed	67
A-2010-00902	All records related to the United States government plan to require tobacco companies to cover half of cigarette packs with health warnings.  (Jan 1, 2010 to Nov 15, 2010).	Disclosed in part	62
A-2010-00938	AERs for the product Biaxin. Report numbers: 000341429, 000341761, 000342485, 000342487, 000344817 and 000346433.	Disclosed in part	22
A-2010-00959	A list from the department's computerized document tracking system of Briefing Notes, Deck Presentations, and Memorandums submitted to the Minister. (Jan 1, 2010 to Dec 5, 2010).	Disclosed in part	144
A-2010-01010	Question Period notes September 1-27, 2010: Assisted Human Reproduction Canada Asbestos - Chrysotile Flavoured Cigars and Cigarillos H1N1 Lessons Learned Lead in Children's Jewellery Natural Health Products - Energy Drinks Obesity - Childhood Obesity Progress on Wait Times Public Health Impacts of Changes to 2011 Census of  Population Supply of Medical Isotopes Alleged Semen Sample Errors Electronic Health Records and Canada Health Infoway Consumer safety - Cell Phones, Cell Phones Towers and WiFi Systems Contraband Tobacco Products Genetically Modified Salmon Bottled Water Drug Shortages	Disclosed in part	72
A-2010-01033	All documents between Health Canada and the CBC/Radio-Canada on the subject of tobacco labelling. (Nov 1, 2010 to Jan 6, 2011).	All disclosed	38
A-2010-01038	All documents under the control of Health Canada from Canadian hospitals in 2010 on narcotics missing or stolen from their inventories.	All disclosed	332
A-2010-01039	All information from meetings between departmental officials and stakeholders regarding Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS). (Jan 1, 2009 to Jan 10, 2011).	Disclosed in part	103
A-2010-01046	All documents of December 9, 2010 question period preparations related to the Tobacco Industry for Minister Aglukkaq.	All disclosed	46
A-2010-01143	AER. Report number: 000349523.	Disclosed in part	29
A-2010-01161	Records on the Canadian approval of the drug Halcion, and any subsequent complaints or concerns raised about the drug.	Disclosed in part	1,036
A-2010-01218	All information on the Document Information Management System (RDIMS). (Oct 1, 2009 to Nov 30, 2010).	All disclosed	244
A-2010-01267	All documents of education, work experience and training for all evaluators, including the Manager, working within or who have worked within the site licensing assessment division. (Jan 1, 2004 to Feb 9, 2011).	Disclosed in part	112
A-2010-01275	Information regarding the product Supreme Collagen, NPN 80017407 by Medelys Laboratories International Inc.	Disclosed in part	254
A-2010-01286	All documents regarding the appeal by Euro Dried & Design Elements to import dried Certified Low Morphine dietary grade poppies.	Disclosed in part	390
A-2010-01322	All correspondence to and from the Minister of Health regarding antibiotics in poultry raised in Canada. (Feb 15, 2010 to Feb 14, 2011).	Disclosed in part	83
A-2010-01328	A list from the department's computerized document tracking system of Briefing Notes, Deck Presentations, and Memorandums submitted to the Minister. (Dec 6, 2010 to Feb 17, 2011).	Disclosed in part	51
A-2010-01331	Information regarding the product Forever Royal Jelly, NPN 80019543 by Aloe Vera of America, Inc.	Disclosed in part	56
A-2010-01337	AERs for the product AVELOX. Report numbers: 000354641, 000355143, 000355317, 000356042, 000356108, 000356311 and 000356436.	Disclosed in part	46
A-2010-01345	Copies of any memorandum email from Health Canada representatives with respect to any adverse reactions or any adverse reaction reports in connection with CEFUROXIME. (Jan 1, 2009 to Feb 23, 2011).	Disclosed in part	6
A-2010-01353	Copies of any memorandum email from Health Canada representatives with respect to any adverse reactions or any adverse reaction reports in connection with SIMVASTATIN. (Jan 1, 2009 to Feb 23, 2011).	Disclosed in part	210
A-2010-01390	AER for the product Norvir. Report number: 000342337.	Disclosed in part	3
A-2010-01406	All emails between Linda Thokle and Lorraine Plummer. (Jan 1, 2010 to Feb 15, 2011).	Disclosed in part	74
A-2010-01407	All emails between Linda Thokle and Yvonne Morriss. (Jan 1, 2010 to Feb 18, 2011)	Disclosed in part	222
A-2010-01438	All radon measurements collected during the Radon Testing in Federal Buildings program. (Jan 1, 2007 to Mar 4, 2011).	All disclosed	83
A-2010-01439	All radon measurements collected in indoor environments in Canada between 1970 and 2005 for households or facilities such as schools, hospitals, correctional facilities, care homes and daycares across the country.	Disclosed in part	1,200
A-2010-01446	All briefing notes prepared for Minister and Deputy Minister concerning Agent Orange and/or 2, 4, 5-T (2, 4, 5 - trichlorophenoxyacetic acid). (Feb 1, 2011 to Mar 8, 2011).	All disclosed	12
A-2010-01460	All local purchase orders processed by in the national capital region for the procurement of Temporary Help Services during the period of February 2011.	No records exist	0
A-2010-01490	AERs for the product Celexa (citalopram). Report numbers: 000351289, 000351561 and 000352008.	Disclosed in part	9
A-2010-01512	AERs for the product Alvesco (ciclesonide inhalation aerosol). Report numbers: 000355692 and 000357666.	Disclosed in part	2
A-2010-01541	All flights from Reserves to Local Hospitals paid for by Health Canada which have originated on the Jean Do'r Prairie Reserve, Garden Rive Reserve and/or Fox Lake and have gone to the Northwest Health Centre in High Level and/or St. Theresa General Hospital in Fort Vermilion between 2005 and 2010.	Disclosed in part	59
A-2010-01577	A listing of the ATI requests submitted to Health Canada for the period of February 1, 2011 to February 28, 2011.	Disclosed in part	44
A-2011-00011	The name of the complaint source on all documents and forms (including C-1007416, 1-1075611 and 1-1075611) pertaining to Bamboobino (2009-2010).	All exempted	0
A-2011-00017	Number of SAP releases for Fotolyn (Pralatrexate) for the month of March 2011.	All disclosed	1
A-2011-00018	Number of SAP releases for Prochymal (Remestemcel-L) for the month of March 2011.	No records exist	0
A-2011-00019	Number of SAP releases for Targretin (Bexaretene) for the month of March 2011.	All disclosed	1
A-2011-00021	Number of SAP releases for Carfilzomib for the month of March 2011.	No records exist	0
A-2011-00022	Number of SAP releases for Cabazitaxel (Jevtana) for the month of March 2011.	No records exist	0
A-2011-00024	Number of SAP releases for Prochymat for the month of March 2011.	No records exist	0
A-2011-00030	A copy of the original request made to Health Canada for access to information. File A-2010-00111.	Disclosed in part	2
A-2011-00034	AER. Report number: 000079168.	Disclosed in part	31
A-2011-00035	AER. Report number: 000089917.	Disclosed in part	28
A-2011-00038	AER. Report number: 000177204.	Disclosed in part	1
A-2011-00039	AER. Report number: 000178253.	Disclosed in part	1
A-2011-00053	FNIH policy and procedures regarding the reclassification of funding arrangements / agreements from Transfer to Set / Integrated Agreement, including notification period for reduction / change of contract and criteria for change in agreements.	All disclosed	43
A-2011-00057	All Callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of March 2011.	Disclosed in part	77
A-2011-00058	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of March 2011.	All disclosed	8
A-2011-00059	All appointments Term and Casual employees by this institution in the National Captital Region during the period of March 2011.	All disclosed	5
A-2011-00060	All callups issued under the terms of the TBIPS Standing Offer (EN578-055605) and amendments for March 2011	All disclosed	8
A-2011-00062	Information regarding the product Sambucol For Kids, NPN 80022538 by Aloe Vera of America, Inc.	No records exist	0
A-2011-00064	Instruction to Access to Information Office during Federal election.	No records exist	0
A-2011-00068	Information regarding the product FLUCONAZOLE-150, DIN 02340046 by Pendopharm.	All exempted	0
A-2011-00069	Information regarding the product FLUCONAZOLE, DIN 02340038 by Pendopharm.	All exempted	0
A-2011-00071	Information regarding the product APO-IBUPROFEN TABLETS 200MG, DIN 00441643 by Apotex Inc.	Disclosed in part	273
A-2011-00083	All documentation submitted to support the licensing of the natural health products, Juice Plus+ Garden Blend (EN-111587) and Juice Plus+ Orchard Blend (EN-111607).	No records exist	0
A-2011-00085	The Product Monograph for Crestor (Rosuvastatin). Notice of Compliance date February 16 2003.	All disclosed	32
A-2011-00092	AER for the product Indapamide. Report number: 000348526.	Disclosed in part	2
A-2011-00093	AER for the product Lozide. Report number: 000351542.	Disclosed in part	1
A-2011-00095	AER for the product Indapamide. Report number: 000348942.	Disclosed in part	1
A-2011-00098	Listing of casual contracts coming to an end in May, June and July 2011.	All disclosed	2
A-2011-00132	AERs for the product Cipralex. Report numbers: 000353183, 000354489, 000358795 and 000347310.	Disclosed in part	10
A-2011-00141	All documents pertaining to the recommendation by Dr. Yvette Bonvalot, that an epidemiological study be carried out at Canadian Forces Base Valcartier and environs concerning exposure to TCE (Trichloroethylene) and other pollutants and/or water supply. (Jan 1, 2001 to Dec 31, 2003).	No records exist	0
A-2011-00158	List of all NPN numbers issued up until April 1, 2011 without all the licence contents.	No records exist	0
A-2011-00171	Full disclosure of the ingredients and dangerous side effects for the following vaccine: - Vaccine Hepatitis B lot number AHBVB787AA Engerix B - Pneumococcal Infection vaccine name: Prevnar - Pentacel, Pediacel, Priorix Tetra, Meningitec	No records exist	0
A-2011-00195	All callups for TBIPS Standing Offer (EN578-055605) in the National Capital Region during the month of April 2011.	No records exist	0
A-2011-00214	All documents regarding changes to the British Columbia Optometrists and Opticians regulations, promulgated on May 1, 2010.	No records exist	0
A-2011-00219	Inspection, complaint, investigation records involving Marchese Pharmacy (Hamilton, Ontario) and 316 James St. N and 340 James St. N (Hamilton, Ontario). Any regulatory-related correspondence with this pharmacy. (Oct 1, 2010 to Feb 1, 2011).	No records exist	0